Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry
2008
Colorectal cancer statistics, 2020
2020 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Colorectal cancer statistics, 2023
2023 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
2010
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Pretreatment 18 F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma——a retrospective study
2015
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
Osteoporosis
2019 Standout
Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively
2013
FDG-PET Detected Thyroid Incidentalomas: Need for Further Investigation?
2006
Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer
2011
Osteoporosis, frailty and fracture: implications for case finding and therapy
2012
The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study
2007
Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
2010
Worldwide prevalence and incidence of osteoporotic vertebral fractures
2017
Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration–voiding–refilling) useful for detecting recurrent bladder cancer?
2012
Targeting HER2
2010
Antibody therapy of cancer
2012 Standout
A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection
2010
Cardiovascular toxicity caused by cancer treatment: strategies for early detection
2009
Imaging of Protein Synthesis: In Vitro and In Vivo Evaluation of 44Sc-DOTA-Puromycin
2012
NCCN Task Force: Clinical Utility of PET in a Variety of Tumor Types
2009
Nasopharyngeal carcinoma
2015 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)
2009
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy
2009
Cardiotoxicity Profile of Trastuzumab
2008
Cancer treatment and survivorship statistics, 2012
2012 Standout
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT
2009
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
2013 Standout
Determinants of life expectancy in medullary thyroid cancer: age does not matter
2006
Diagnostic Accuracy of 18F-FDG PET in Restaging Patients with Medullary Thyroid Carcinoma and Elevated Calcitonin Levels
2007
Urinary excretion of tetrahydrophtalimide in fruit growers with dermal exposure to captan
1995
The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology
2011
Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma
2012
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma
2012
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Medullary Thyroid Carcinoma without Marked Elevation of Calcitonin: A Diagnostic and Surveillance Dilemma
2008
Cancer Therapy–Induced Cardiac Toxicity in Early Breast Cancer
2012
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
2010 Standout
Monoclonal Antibodies for Cancer Therapy
2012 StandoutNobel
Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy
2007
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications
2007
Colorectal cancer statistics, 2017
2017 Standout
A Quantitative Approach for Estimating Exposure to Pesticides in the Agricultural Health Study
2002 Standout
N‐Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease
2019
18F-Dihydroxyphenylalanine PET in Patients with Biochemical Evidence of Medullary Thyroid Cancer: Relation to Tumor Differentiation
2008
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Erratum: Cardiotoxicity of anticancer treatments
2015
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Analysis of nanoparticle delivery to tumours
2016 Standout
Guidelines for the management of thyroid cancer
2014 Standout
[The role of scintigraphy with the use of 99mTc-HYNIC-TOC in the diagnosis of medullary thyroid carcinoma].
2007
Current Update on Medullary Thyroid Carcinoma
2013
Cardiac toxicity in cancer survivors
2013
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Imaging Medullary Thyroid Carcinoma with Persistent Elevated Calcitonin Levels
2007
PET/CT Imaging of Thyroid Cancer
2011
Works of P.L. Jager being referenced
111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: A clue to uncover the mechanisms of trastuzumab-related cardiotoxicity
2007
Molecular imaging: what can be used today
2005
Vertebral fracture prevalence in a referral population of 750 Canadian men and women
2012
Determination of tetrahydrophtalimide and 2-thiothiazolidine-4-carboxylic acid, urinary metabolites of the fungicide captan, in rats and humans
1991
Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson’s disease and healthy controls
2008
Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer
2008
Impact of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients with Biochemical Evidence of Recurrent or Residual Medullary Thyroid Cancer
2004
[Efficient and improved diagnosis of osteoporosis by simultaneous bone density measurement and spinal morphometry].
2008
Limited additional value of positron emission tomography in staging oesophageal cancer
2007